[Effects of time of recombinant luteinized hormone supplementation on pregnancy outcomes of women with advanced reproductive age during follicular-phase long protocol].

Wang, L; Wang, J; Hu, Y Q; Liu, J Y; Diao, F Y

Wang, L; Wang, J; Hu, Y Q; Liu, J Y; Diao, F Y.

Afiliação

Wang L; Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Wang J; Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Hu YQ; Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Liu JY; Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Diao FY; Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Zhonghua Fu Chan Ke Za Zhi ; 57(10): 758-766, 2022 Oct 25.

Article em Zh | MEDLINE | ID: mdl-36299179

Assuntos

Hormônio Antimülleriano; Resultado da Gravidez; Gravidez; Feminino; Masculino; Humanos; Fase Folicular; Estudos Retrospectivos; Sêmen; Fertilização in vitro/métodos; Taxa de Gravidez; Indução da Ovulação/métodos; Hormônio Foliculoestimulante; Gonadotropinas; Suplementos Nutricionais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resultado da Gravidez / Hormônio Antimülleriano Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Pregnancy Idioma: Zh Revista: Zhonghua Fu Chan Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google